These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


92 related items for PubMed ID: 3409547

  • 21. Induction of various autoantibodies by mutant gene lpr in several strains of mice.
    Izui S, Kelley VE, Masuda K, Yoshida H, Roths JB, Murphy ED.
    J Immunol; 1984 Jul; 133(1):227-33. PubMed ID: 6609979
    [Abstract] [Full Text] [Related]

  • 22. Dichotomic effects of IFN-gamma on the development of systemic lupus erythematosus-like syndrome in MRL-lpr / lpr mice.
    Nicoletti F, Di Marco R, Zaccone P, Xiang M, Magro G, Grasso S, Morrone S, Santoni A, Shoenfeld Y, Garotta G, Meroni P.
    Eur J Immunol; 2000 Feb; 30(2):438-47. PubMed ID: 10671199
    [Abstract] [Full Text] [Related]

  • 23. Angiotensin inhibition reduces glomerular damage and renal chemokine expression in MRL/lpr mice.
    Pérez De Lema G, De Wit C, Cohen CD, Nieto E, Molina A, Banas B, Luckow B, Vicente AB, Mampaso F, Schlöndorff D.
    J Pharmacol Exp Ther; 2003 Oct; 307(1):275-81. PubMed ID: 12954793
    [Abstract] [Full Text] [Related]

  • 24. Control of spontaneous B lymphocyte autoimmunity with adenovirus-encoded soluble TACI.
    Liu W, Szalai A, Zhao L, Liu D, Martin F, Kimberly RP, Zhou T, Carter RH.
    Arthritis Rheum; 2004 Jun; 50(6):1884-96. PubMed ID: 15188365
    [Abstract] [Full Text] [Related]

  • 25. Granulocyte-colony stimulating factor treatment of lupus autoimmune disease in MRL-lpr/lpr mice.
    Zavala F, Masson A, Hadaya K, Ezine S, Schneider E, Babin O, Bach JF.
    J Immunol; 1999 Nov 01; 163(9):5125-32. PubMed ID: 10528219
    [Abstract] [Full Text] [Related]

  • 26. Treatment of autoimmune MRL/Mp-lpr/lpr mice with cholera toxin.
    Fan JL, Himeno K, Tsuru S, Nomoto K.
    Clin Exp Immunol; 1987 Oct 01; 70(1):94-101. PubMed ID: 3500817
    [Abstract] [Full Text] [Related]

  • 27. Viral double-stranded RNA aggravates lupus nephritis through Toll-like receptor 3 on glomerular mesangial cells and antigen-presenting cells.
    Patole PS, Gröne HJ, Segerer S, Ciubar R, Belemezova E, Henger A, Kretzler M, Schlöndorff D, Anders HJ.
    J Am Soc Nephrol; 2005 May 01; 16(5):1326-38. PubMed ID: 15772251
    [Abstract] [Full Text] [Related]

  • 28. Critical role of TLR2 and TLR4 in autoantibody production and glomerulonephritis in lpr mutation-induced mouse lupus.
    Lartigue A, Colliou N, Calbo S, François A, Jacquot S, Arnoult C, Tron F, Gilbert D, Musette P.
    J Immunol; 2009 Nov 15; 183(10):6207-16. PubMed ID: 19841185
    [Abstract] [Full Text] [Related]

  • 29. Reduction in cis-diamminedichloroplatinum(II)-induced cytotoxicity, sister chromatid exchange, and DNA interstrand cross-links in 9L cells treated with the polyamine biosynthesis inhibitor (2R,5R)-6-heptyne-2,5-diamine.
    Milam KM, Hunter KJ, Deen DF, Marton LJ.
    Cancer Res; 1989 Dec 15; 49(24 Pt 1):6945-8. PubMed ID: 2582436
    [Abstract] [Full Text] [Related]

  • 30. Treatment of lupus-prone NZB/NZW F1 mice with recombinant soluble Fc gamma receptor II (CD32).
    Werwitzke S, Trick D, Sondermann P, Kamino K, Schlegelberger B, Kniesch K, Tiede A, Jacob U, Schmidt RE, Witte T.
    Ann Rheum Dis; 2008 Feb 15; 67(2):154-61. PubMed ID: 17557887
    [Abstract] [Full Text] [Related]

  • 31. The effect of a selective estrogen receptor modulator on the progression of spontaneous autoimmune disease in MRL lpr/lpr mice.
    Apelgren LD, Bailey DL, Fouts RL, Short L, Bryan N, Evans GF, Sandusky GE, Zuckerman SH, Glasebrook A, Bumol TF.
    Cell Immunol; 1996 Oct 10; 173(1):55-63. PubMed ID: 8871601
    [Abstract] [Full Text] [Related]

  • 32. IFN-gamma receptor signaling is essential for the initiation, acceleration, and destruction of autoimmune kidney disease in MRL-Fas(lpr) mice.
    Schwarting A, Wada T, Kinoshita K, Tesch G, Kelley VR.
    J Immunol; 1998 Jul 01; 161(1):494-503. PubMed ID: 9647261
    [Abstract] [Full Text] [Related]

  • 33. Fate of immune complexes, glomerulonephritis, and cell-mediated vasculitis in lupus-prone MRL/Mp lpr/lpr mice.
    Cruse JM, Lewis RE, Dilioglou S.
    Exp Mol Pathol; 2000 Dec 01; 69(3):211-22. PubMed ID: 11115362
    [Abstract] [Full Text] [Related]

  • 34. Plasma levels of nucleosomes and nucleosome-autoantibody complexes in murine lupus: effects of disease progression and lipopolyssacharide administration.
    Licht R, van Bruggen MC, Oppers-Walgreen B, Rijke TP, Berden JH.
    Arthritis Rheum; 2001 Jun 01; 44(6):1320-30. PubMed ID: 11407691
    [Abstract] [Full Text] [Related]

  • 35. Polyclonal B cell activation arises from different mechanisms in lupus-prone (NZB x NZW)F1 and MRL/MpJ-lpr/lpr mice.
    Merino R, Iwamoto M, Fossati L, Izui S.
    J Immunol; 1993 Dec 01; 151(11):6509-16. PubMed ID: 7902378
    [Abstract] [Full Text] [Related]

  • 36. Beneficial effects of a polyamine biosynthesis inhibitor on lupus in MRL-lpr/lpr mice.
    Thomas TJ, Messner RP.
    Clin Exp Immunol; 1989 Nov 01; 78(2):239-44. PubMed ID: 12412756
    [Abstract] [Full Text] [Related]

  • 37. FcgammaRIIB deficiency with Fas mutation is sufficient for the development of systemic autoimmune disease.
    Yajima K, Nakamura A, Sugahara A, Takai T.
    Eur J Immunol; 2003 Apr 01; 33(4):1020-9. PubMed ID: 12672068
    [Abstract] [Full Text] [Related]

  • 38. Pattern of anti-small nuclear ribonucleoprotein antibodies in MRL/Mp-lpr/lpr mice suggests that the intact U1 snRNP particle is their autoimmunogenic target.
    Fatenejad S, Brooks W, Schwartz A, Craft J.
    J Immunol; 1994 Jun 01; 152(11):5523-31. PubMed ID: 7514640
    [Abstract] [Full Text] [Related]

  • 39. Inhibition of alloantigen-induced cytolytic T lymphocytes in vitro with (2R,5R)-6-heptyne-2,5-diamine, an irreversible inhibitor of ornithine decarboxylase.
    Bowlin TL, Davis GF, McKown BJ.
    Cell Immunol; 1988 Feb 01; 111(2):443-50. PubMed ID: 3123076
    [Abstract] [Full Text] [Related]

  • 40. Regulation of ornithine decarboxylase in the kidney of autoimmune mice with the lpr gene.
    Hsu HC, Seibold JR, Thomas TJ.
    Autoimmunity; 1994 Feb 01; 19(4):253-64. PubMed ID: 7578852
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 5.